Exploring the Protein Landscape of Dormant Mycobacterium tuberculosis Through In Vitro Functional Studies

The investigation of functional proteins during dormancy in Mycobacterium tuberculosis (Mtb) through in vitro experiments provides crucial insights into the bacterium's survival mechanisms and pathogenicity. Dormancy constitutes a pivotal phase in the Mtb life cycle, enabling the pathogen to persist within hostile host environments, evade immune defenses, and establish latent tuberculosis infections. Although dormancy is often conceptually divided into early, mid, and late stages, these phases frequently overlap, representing a continuum of physiological and molecular adaptations rather than distinct, isolated steps. During early dormancy, which typically occurs within the initial days to weeks following exposure to stressors such as hypoxia and nutrient limitation, Mtb initiates rapid transcriptional and proteomic reprogramming. This reprogramming involves the upregulation of genes associated with stress response, anaerobic metabolism, and cell wall remodeling. These molecular changes drive initial morphological adaptations, including cell wall thickening and a marked reduction in replication rates, signaling the transition from active growth to a nonreplicating persistent state. Mid-dormancy, spanning several weeks to months, is characterized by further metabolic downregulation coupled with enhanced resistance to environmental stresses. Proteins involved in energy conservation, detoxification processes, and maintenance of cellular integrity become increasingly prominent during this phase. Morphologically, Mtb bacilli undergo size reduction, exhibit altered cell division patterns such as budding, and display structural transformations including the folding of rod-shaped cells into ovoid forms. These adaptations collectively support the bacterium's long-term survival under sustained hostile conditions. Late dormancy, which may extend over months or even years, is defined by the stabilization of a metabolically quiescent state accompanied by profound physiological modifications. Morphological hallmarks of this stage include the formation of specialized spore-like cells and filterable nonacid-fast forms. Despite these altered physical characteristics, the cells remain metabolically active, enabling Mtb to withstand prolonged immune pressure and antibiotic exposure. This stage underlies the bacterium's capacity for latent infection and potential reactivation. While the tripartite framework of early, mid, and late dormancy provides a useful conceptual model, the transitions between these stages are naturally gradual and overlapping. Overlapping genetic and phenotypic changes underscore the dynamic and continuous nature of dormancy in Mtb. A comprehensive understanding of the functional proteins and regulatory networks operative throughout these stages is essential not only for elucidating the mechanisms that sustain Mtb during latency but also for identifying novel therapeutic targets. Targeting these pathways holds promise for preventing reactivation and improving the efficacy of tuberculosis treatment.